SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001343084-05-000002
Filing Date
2005-11-01
Accepted
2005-11-01 15:56:47
Documents
2
Period of Report
2005-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1592
2 POWER OF ATTORNEY richardsonpoa.htm EX-24 3644
  Complete submission text file 0001343084-05-000002.txt   7050
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 3151 SOUTH 17TH STREET WILMINGTON NC 28412
Business Address 910-251-0081
Richardson William W (Reporting) CIK: 0001343084 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27570 | Film No.: 051169832